Chief Admin. Ofcr. & GC · SUTRO BIOPHARMA, INC. · SUTRO BIOPHARMA, INC. — Restricted Stock Units (RSUs)
Side
M
Value
—
Shares
2,356
Price
—
Executed
Mar 2, 2026
Disclosed
Mar 3, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Mar 2 executedMar 3, 2026 disclosed
STRO · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+9 / 25
No reported dollar value · 50.0% of prior position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
SUTRO BIOPHARMA, INC. — Restricted Stock Units (RSUs)
Ticker
STRO
Shares
2,356
Price per share
$0
Execution date (reported)
Mar 2, 2026
Owned after transaction
7,069 shares
Days from execution to publication
1
What this establishes
Pauling David filed this Form 4 reporting a option exercise of STRO on Mar 2, 2026. It became public on Mar 3, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Admin. Ofcr. & GC
Pauling Davidcik:0002063633
Issuer
SUTRO BIOPHARMA, INC.cik:0001382101
Revision history · 0
No field has changed since this record was first ingested.
